-
1
-
-
84873327794
-
Global variation in the prevalence and incidence of major depressive disorder: A systematic review of the epidemiological literature
-
Ferrari AJ, Somerville AJ, Baxter AJ, Norman R, Patten SB, Vos T, et al. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med 2013;43:471-481.
-
(2013)
Psychol Med
, vol.43
, pp. 471-481
-
-
Ferrari, A.J.1
Somerville, A.J.2
Baxter, A.J.3
Norman, R.4
Patten, S.B.5
Vos, T.6
-
3
-
-
33746084813
-
History of the use of antidepressants in primary care
-
Lieberman JA. History of the use of antidepressants in primary care. J Clin Psychiatry 2003;5(Suppl 7):6-10.
-
(2003)
J Clin Psychiatry
, vol.5
, Issue.SUPPL. 7
, pp. 6-10
-
-
Lieberman, J.A.1
-
4
-
-
3042631898
-
Antidepressants and brain monoaminergic systems: A dimensional approach to understanding their behavioural effects in depression and anxiety disorders
-
Morilak DA, Frazer A. Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders. Int J Neuropsychopharmacol 2004;7:193-218.
-
(2004)
Int J Neuropsychopharmacol
, vol.7
, pp. 193-218
-
-
Morilak, D.A.1
Frazer, A.2
-
6
-
-
0012967396
-
Mechanism of action of antidepressants and mood stabilizers
-
Davis KL, Charney D, Coyle JT, Nemeroff C, editors. Philadelphia: Lippincott Williams & Wilkins
-
Lenox RH, Frazer A. Mechanism of action of antidepressants and mood stabilizers. In: Davis KL, Charney D, Coyle JT, Nemeroff C, editors. Neuropsychopharmacology: The fifth generation of progress. Philadelphia: Lippincott Williams & Wilkins;2002. p.1139-1163.
-
(2002)
Neuropsychopharmacology: The Fifth Generation of Progress
, pp. 1139-1163
-
-
Lenox, R.H.1
Frazer, A.2
-
8
-
-
0018425438
-
A new depression scale designed to be sensitive to change
-
Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389.
-
(1979)
Br J Psychiatry
, vol.134
, pp. 382-389
-
-
Montgomery, S.A.1
Asberg, M.2
-
9
-
-
0026006469
-
Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence
-
Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991;48:851-855.
-
(1991)
Arch Gen Psychiatry
, vol.48
, pp. 851-855
-
-
Frank, E.1
Prien, R.F.2
Jarrett, R.B.3
Keller, M.B.4
Kupfer, D.J.5
Lavori, P.W.6
-
10
-
-
33747339984
-
Report by the ACNP task force on response and remission in major depressive disorder
-
ACNP Task Force
-
Rush AJ, Kraemer HC, Sackeim HA, Fava M, Trivedi MH, Frank E, et al ACNP Task Force. Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology 2006;31:1841-1853.
-
(2006)
Neuropsychopharmacology
, vol.31
, pp. 1841-1853
-
-
Rush, A.J.1
Kraemer, H.C.2
Sackeim, H.A.3
Fava, M.4
Trivedi, M.H.5
Frank, E.6
-
11
-
-
84870824224
-
Is there anything really novel on the antidepressant horizon?
-
Murrough JW, Charney DS. Is there anything really novel on the antidepressant horizon? Curr Psychiatry Rep 2012;14:643-649.
-
(2012)
Curr Psychiatry Rep
, vol.14
, pp. 643-649
-
-
Murrough, J.W.1
Charney, D.S.2
-
12
-
-
34248385534
-
Treatment-resistant unipolar depression
-
Lader M, Naber D, editors. London (UK):Martin Dunitz Ltd.
-
Burrows GD, Norman TR. Treatment-resistant unipolar depression. In: Lader M, Naber D, editors. Difficult clinical problems in psychiatry. London (UK):Martin Dunitz Ltd.; 1999. p.57-73.
-
(1999)
Difficult Clinical Problems in Psychiatry
, pp. 57-73
-
-
Burrows, G.D.1
Norman, T.R.2
-
13
-
-
84876324599
-
The economic burden of treatment-resistant depression
-
Olchanski N, McInnis Myers M, Halseth M, Cyr PL, Bockstedt L, Goss TF, et al. The economic burden of treatment-resistant depression. Clin Ther 2013;35:512-522.
-
(2013)
Clin Ther
, vol.35
, pp. 512-522
-
-
Olchanski, N.1
McInnis Myers, M.2
Halseth, M.3
Cyr, P.L.4
Bockstedt, L.5
Goss, T.F.6
-
14
-
-
34248381347
-
Definition, assessment, and staging of treatment-resistant refractory major depression: A review of current concepts and methods
-
Berlim MT, Turecki G. Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Can J Psychiatry 2007;52:46-54.
-
(2007)
Can J Psychiatry
, vol.52
, pp. 46-54
-
-
Berlim, M.T.1
Turecki, G.2
-
15
-
-
0031464430
-
When at first you don't succeed: Sequential strategies for antidepressant nonresponders
-
Thase ME, Rush AJ. When at first you don't succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry 1997;58(Suppl)13:23-29.
-
(1997)
J Clin Psychiatry
, vol.58
, Issue.13 SUPPL.
, pp. 23-29
-
-
Thase, M.E.1
Rush, A.J.2
-
16
-
-
84857367167
-
Staging methods for treatment resistant depression. A systematic review
-
Ruhé HG, van Rooijen G, Spijker J, Peeters FP, Schene AH. Staging methods for treatment resistant depression. A systematic review. J Affect Disord 2012;137:35-45.
-
(2012)
J Affect Disord
, vol.137
, pp. 35-45
-
-
Ruhé, H.G.1
Van Rooijen, G.2
Spijker, J.3
Peeters, F.P.4
Schene, A.H.5
-
18
-
-
76449102471
-
No evidence for switching the antidepressant: Systematic review and meta-analysis of RCTs of a common therapeutic strategy
-
Bschor T, Baethge C. No evidence for switching the antidepressant: systematic review and meta-analysis of RCTs of a common therapeutic strategy. Acta Psychiatr Scand 2010;121:174-179.
-
(2010)
Acta Psychiatr Scand
, vol.121
, pp. 174-179
-
-
Bschor, T.1
Baethge, C.2
-
19
-
-
33845968599
-
Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: A systematic review
-
Ruhé HG, Huyser J, Swinkels JA, Schene AH. Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review. J Clin Psychiatry 2006;67:1836-1855.
-
(2006)
J Clin Psychiatry
, vol.67
, pp. 1836-1855
-
-
Ruhé, H.G.1
Huyser, J.2
Swinkels, J.A.3
Schene, A.H.4
-
20
-
-
79960583176
-
Switching antidepressant class does not improve response or remission in treatment-resistant depression
-
Souery D, Serretti A, Calati R, Oswald P, Massat I, Konstantinidis A, et al. Switching antidepressant class does not improve response or remission in treatment-resistant depression. J Clin Psychopharmacol 2011;31:512-516.
-
(2011)
J Clin Psychopharmacol
, vol.31
, pp. 512-516
-
-
Souery, D.1
Serretti, A.2
Calati, R.3
Oswald, P.4
Massat, I.5
Konstantinidis, A.6
-
21
-
-
24344464361
-
The current state of cognitive therapy: A 40-year retrospective
-
Beck AT. The current state of cognitive therapy: a 40-year retrospective. Arch Gen Psychiatry 2005;62:953-959.
-
(2005)
Arch Gen Psychiatry
, vol.62
, pp. 953-959
-
-
Beck, A.T.1
-
22
-
-
77954277171
-
Cognitive behavioral therapy for mood disorders: Efficacy, moderators and mediators
-
Driessen E, Hollon SD. Cognitive behavioral therapy for mood disorders: efficacy, moderators and mediators. Psychiatr Clin North Am 2010;33:537-555.
-
(2010)
Psychiatr Clin North Am
, vol.33
, pp. 537-555
-
-
Driessen, E.1
Hollon, S.D.2
-
23
-
-
0034682305
-
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression
-
Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000;342:1462-1470.
-
(2000)
N Engl J Med
, vol.342
, pp. 1462-1470
-
-
Keller, M.B.1
McCullough, J.P.2
Klein, D.N.3
Arnow, B.4
Dunner, D.L.5
Gelenberg, A.J.6
-
24
-
-
34249337130
-
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: A STAR*D report
-
Thase ME, Friedman ES, Biggs MM, Wisniewski SR, Trivedi MH, Luther JF, et al. Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. Am J Psychiatry 2007;164:739-752.
-
(2007)
Am J Psychiatry
, vol.164
, pp. 739-752
-
-
Thase, M.E.1
Friedman, E.S.2
Biggs, M.M.3
Wisniewski, S.R.4
Trivedi, M.H.5
Luther, J.F.6
-
25
-
-
79952818711
-
Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: A preliminary meta-analysis
-
Guidi J, Fava GA, Fava M, Papakostas GI. Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: a preliminary meta-analysis. Psychol Med 2011;41:321-331.
-
(2011)
Psychol Med
, vol.41
, pp. 321-331
-
-
Guidi, J.1
Fava, G.A.2
Fava, M.3
Papakostas, G.I.4
-
26
-
-
53149092475
-
The co-administration of quetiapine or placebo to cognitive-behavior therapy in treatment refractory depression: A preliminary trial
-
Chaput Y, Magnan A, Gendron A. The co-administration of quetiapine or placebo to cognitive-behavior therapy in treatment refractory depression: a preliminary trial. BMC Psychiatry 2008;8:73.
-
(2008)
BMC Psychiatry
, vol.8
, pp. 73
-
-
Chaput, Y.1
Magnan, A.2
Gendron, A.3
-
27
-
-
0035224419
-
Management of treatment-resistant depression: Psychotherapeutic perspectives
-
Thase ME, Friedman ES, Howland RH. Management of treatment-resistant depression: psychotherapeutic perspectives. J Clin Psychiatry 2001;62(Suppl 18):18-24.
-
(2001)
J Clin Psychiatry
, vol.62
, Issue.SUPPL. 18
, pp. 18-24
-
-
Thase, M.E.1
Friedman, E.S.2
Howland, R.H.3
-
28
-
-
79958261494
-
Examination of the utility of psychotherapy for patients with treatment resistant depression: A systematic review
-
Trivedi RB, Nieuwsma JA, Williams JW Jr. Examination of the utility of psychotherapy for patients with treatment resistant depression: a systematic review. J Gen Intern Med 2011;26:643-650.
-
(2011)
J Gen Intern Med
, vol.26
, pp. 643-650
-
-
Trivedi, R.B.1
Nieuwsma, J.A.2
Williams Jr., J.W.3
-
29
-
-
84873162194
-
Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: Results of the CoBalT randomised controlled trial
-
Wiles N, Thomas L, Abel A, Ridgway N, Turner N, Campbell J, et al. Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial. Lancet 2013;381:375-384.
-
(2013)
Lancet
, vol.381
, pp. 375-384
-
-
Wiles, N.1
Thomas, L.2
Abel, A.3
Ridgway, N.4
Turner, N.5
Campbell, J.6
-
30
-
-
0347415656
-
Modulation of cortical-limbic pathways in major depression: Treatment-specific effects of cognitive behavior therapy
-
Goldapple K, Segal Z, Garson C, Lau M, Bieling P, Kennedy S, et al. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry 2004;61:34-41.
-
(2004)
Arch Gen Psychiatry
, vol.61
, pp. 34-41
-
-
Goldapple, K.1
Segal, Z.2
Garson, C.3
Lau, M.4
Bieling, P.5
Kennedy, S.6
-
31
-
-
34249302076
-
Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial
-
Kennedy SH, Konarski JZ, Segal ZV, Lau MA, Bieling PJ, McIntyre RS, et al. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am J Psychiatry 2007;164:778-788.
-
(2007)
Am J Psychiatry
, vol.164
, pp. 778-788
-
-
Kennedy, S.H.1
Konarski, J.Z.2
Segal, Z.V.3
Lau, M.A.4
Bieling, P.J.5
McIntyre, R.S.6
-
32
-
-
84870887769
-
Somatic therapies for treatment-resistant depression: ECT, TMS, VNS, DBS
-
Cusin C, Dougherty DD. Somatic therapies for treatment-resistant depression: ECT, TMS, VNS, DBS. Biol Mood Anxiety Disord 2012;2:14.
-
(2012)
Biol Mood Anxiety Disord
, vol.2
, pp. 14
-
-
Cusin, C.1
Dougherty, D.D.2
-
33
-
-
33750339118
-
Vagal nerve stimulation: Overview and implications for anesthesiologists
-
Hatton KW, McLarney JT, Pittman T, Fahy BG. Vagal nerve stimulation: overview and implications for anesthesiologists. Anesth Analg 2006;103:1241-1249.
-
(2006)
Anesth Analg
, vol.103
, pp. 1241-1249
-
-
Hatton, K.W.1
McLarney, J.T.2
Pittman, T.3
Fahy, B.G.4
-
34
-
-
45149095307
-
Induction of c-Fos and DeltaFosB immunoreactivity in rat brain by Vagal nerve stimulation
-
Cunningham JT, Mifflin SW, Gould GG, Frazer A. Induction of c-Fos and DeltaFosB immunoreactivity in rat brain by Vagal nerve stimulation. Neuropsychopharmacology 2008;33:1884-1895.
-
(2008)
Neuropsychopharmacology
, vol.33
, pp. 1884-1895
-
-
Cunningham, J.T.1
Mifflin, S.W.2
Gould, G.G.3
Frazer, A.4
-
35
-
-
24044436792
-
Vagus nerve stimulation for treatment-resistant depression: A randomized, controlled acute phase trial
-
Rush AJ, Marangell LB, Sackeim HA, George MS, Brannan SK, Davis SM, et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry 2005;58:347-354.
-
(2005)
Biol Psychiatry
, vol.58
, pp. 347-354
-
-
Rush, A.J.1
Marangell, L.B.2
Sackeim, H.A.3
George, M.S.4
Brannan, S.K.5
Davis, S.M.6
-
36
-
-
24044505312
-
Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: A naturalistic study
-
Rush AJ, Sackeim HA, Marangell LB, George MS, Brannan SK, Davis SM, et al. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry 2005;58:355-363.
-
(2005)
Biol Psychiatry
, vol.58
, pp. 355-363
-
-
Rush, A.J.1
Sackeim, H.A.2
Marangell, L.B.3
George, M.S.4
Brannan, S.K.5
Davis, S.M.6
-
37
-
-
24044463171
-
A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression
-
George MS, Rush AJ, Marangell LB, Sackeim HA, Brannan SK, Davis SM, et al. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry 2005;58:364-373.
-
(2005)
Biol Psychiatry
, vol.58
, pp. 364-373
-
-
George, M.S.1
Rush, A.J.2
Marangell, L.B.3
Sackeim, H.A.4
Brannan, S.K.5
Davis, S.M.6
-
38
-
-
41649085179
-
Vagus nerve stimulation for depression: Efficacy and safety in a European study
-
Schlaepfer TE, Frick C, Zobel A, Maier W, Heuser I, Bajbouj M, et al. Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychol Med 2008;38:651-661.
-
(2008)
Psychol Med
, vol.38
, pp. 651-661
-
-
Schlaepfer, T.E.1
Frick, C.2
Zobel, A.3
Maier, W.4
Heuser, I.5
Bajbouj, M.6
-
39
-
-
84888358513
-
Vagus nerve stimulation for chronic major depressive disorder: 12-month outcomes in highly treatment-refractory patients
-
Christmas D, Steele JD, Tolomeo S, Eljamel MS, Matthews K. Vagus nerve stimulation for chronic major depressive disorder: 12-month outcomes in highly treatment-refractory patients. J Affect Disord 2013;150:1221-1225.
-
(2013)
J Affect Disord
, vol.150
, pp. 1221-1225
-
-
Christmas, D.1
Steele, J.D.2
Tolomeo, S.3
Eljamel, M.S.4
Matthews, K.5
-
40
-
-
77952330742
-
Two-year outcome of vagus nerve stimulation in treatment-resistant depression
-
Bajbouj M, Merkl A, Schlaepfer TE, Frick C, Zobel A, Maier W, et al. Two-year outcome of vagus nerve stimulation in treatment-resistant depression. J Clin Psychopharmacol 2010;30:273-281.
-
(2010)
J Clin Psychopharmacol
, vol.30
, pp. 273-281
-
-
Bajbouj, M.1
Merkl, A.2
Schlaepfer, T.E.3
Frick, C.4
Zobel, A.5
Maier, W.6
-
41
-
-
26644452527
-
Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes
-
Nahas Z, Marangell LB, Husain MM, Rush AJ, Sackeim HA, Lisanby SH, et al. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry 2005;66:1097-1104.
-
(2005)
J Clin Psychiatry
, vol.66
, pp. 1097-1104
-
-
Nahas, Z.1
Marangell, L.B.2
Husain, M.M.3
Rush, A.J.4
Sackeim, H.A.5
Lisanby, S.H.6
-
42
-
-
47949128934
-
Safety and efficacy of vagus nerve stimulation in treatment-resistant depression. A systematic review
-
Daban C, Martinez-Aran A, Cruz N, Vieta E. Safety and efficacy of Vagus Nerve Stimulation in treatment-resistant depression. A systematic review. J Affect Disord 2008;110:1-15.
-
(2008)
J Affect Disord
, vol.110
, pp. 1-15
-
-
Daban, C.1
Martinez-Aran, A.2
Cruz, N.3
Vieta, E.4
-
43
-
-
34548360206
-
Durability of antidepressant response to vagus nerve stimulation (VNS)
-
Sackeim HA, Brannan SK, Rush AJ, George MS, Marangell LB, Allen J. Durability of antidepressant response to vagus nerve stimulation (VNS). Int J Neuropsychopharmacol 2007;10:817-826.
-
(2007)
Int J Neuropsychopharmacol
, vol.10
, pp. 817-826
-
-
Sackeim, H.A.1
Brannan, S.K.2
Rush, A.J.3
George, M.S.4
Marangell, L.B.5
Allen, J.6
-
44
-
-
84868092583
-
Mortality and suicide risk in treatment-resistant depression: An observational study of the long-term impact of intervention
-
Olin B, Jayewardene AK, Bunker M, Moreno F. Mortality and suicide risk in treatment-resistant depression: an observational study of the long-term impact of intervention. PLoS One 2012;7:e48002.
-
(2012)
PLoS One
, vol.7
-
-
Olin, B.1
Jayewardene, A.K.2
Bunker, M.3
Moreno, F.4
-
45
-
-
84879288188
-
Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: Acute and chronic effects
-
Aaronson ST, Carpenter LL, Conway CR, Reimherr FW, Lisanby SH, Schwartz TL, et al. Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects. Brain Stimul 2013;6:631-640.
-
(2013)
Brain Stimul
, vol.6
, pp. 631-640
-
-
Aaronson, S.T.1
Carpenter, L.L.2
Conway, C.R.3
Reimherr, F.W.4
Lisanby, S.H.5
Schwartz, T.L.6
-
46
-
-
0020450131
-
Brainstem projections of sensory and motor components of the vagus nerve in the rat
-
Kalia M, Sullivan JM. Brainstem projections of sensory and motor components of the vagus nerve in the rat. J Comp Neurol 1982;211:248-265.
-
(1982)
J Comp Neurol
, vol.211
, pp. 248-265
-
-
Kalia, M.1
Sullivan, J.M.2
-
47
-
-
17444369079
-
Recordings from the rat locus coeruleus during acute vagal nerve stimulation in the anaesthetised rat
-
Groves DA, Bowman EM, Brown VJ. Recordings from the rat locus coeruleus during acute vagal nerve stimulation in the anaesthetised rat. Neurosci Lett 2005;379:174-179.
-
(2005)
Neurosci Lett
, vol.379
, pp. 174-179
-
-
Groves, D.A.1
Bowman, E.M.2
Brown, V.J.3
-
48
-
-
0029648486
-
The spinoparabrachial pathway: Shedding new light on an old path
-
Saper CB. The spinoparabrachial pathway: shedding new light on an old path. J Comp Neurol 1995;353:477-479.
-
(1995)
J Comp Neurol
, vol.353
, pp. 477-479
-
-
Saper, C.B.1
-
49
-
-
0028803065
-
Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve
-
Naritoku DK, Terry WJ, Helfert RH. Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve. Epilepsy Res 1995;22:53-62.
-
(1995)
Epilepsy Res
, vol.22
, pp. 53-62
-
-
Naritoku, D.K.1
Terry, W.J.2
Helfert, R.H.3
-
50
-
-
84860004427
-
Comparison of DeltaFosB immunoreactivity induced by vagal nerve stimulation with that caused by pharmacologically diverse antidepressants
-
Furmaga H, Sadhu M, Frazer A. Comparison of DeltaFosB immunoreactivity induced by vagal nerve stimulation with that caused by pharmacologically diverse antidepressants. J Pharmacol Exp Ther 2012;341:317-325.
-
(2012)
J Pharmacol Exp Ther
, vol.341
, pp. 317-325
-
-
Furmaga, H.1
Sadhu, M.2
Frazer, A.3
-
51
-
-
0141992112
-
A review of functional neuroimaging studies of vagus nerve stimulation (VNS)
-
Chae JH, Nahas Z, Lomarev M, Denslow S, Lorberbaum JP, Bohning DE, et al. A review of functional neuroimaging studies of vagus nerve stimulation (VNS). J Psychiatr Res 2003;37:443-455.
-
(2003)
J Psychiatr Res
, vol.37
, pp. 443-455
-
-
Chae, J.H.1
Nahas, Z.2
Lomarev, M.3
Denslow, S.4
Lorberbaum, J.P.5
Bohning, D.E.6
-
52
-
-
79951851593
-
Chronic vagus nerve stimulation for treatment-resistant depression increases regional cerebral blood flow in the dorsolateral prefrontal cortex
-
Kosel M, Brockmann H, Frick C, Zobel A, Schlaepfer TE. Chronic vagus nerve stimulation for treatment-resistant depression increases regional cerebral blood flow in the dorsolateral prefrontal cortex. Psychiatry Res 2011;191:153-159.
-
(2011)
Psychiatry Res
, vol.191
, pp. 153-159
-
-
Kosel, M.1
Brockmann, H.2
Frick, C.3
Zobel, A.4
Schlaepfer, T.E.5
-
53
-
-
33846305392
-
Serial vagus nerve stimulation functional MRI in treatment-resistant depression
-
Nahas Z, Teneback C, Chae JH, Mu Q, Molnar C, Kozel FA, et al. Serial vagus nerve stimulation functional MRI in treatment-resistant depression. Neuropsychopharmacology 2007;32:1649-1660.
-
(2007)
Neuropsychopharmacology
, vol.32
, pp. 1649-1660
-
-
Nahas, Z.1
Teneback, C.2
Chae, J.H.3
Mu, Q.4
Molnar, C.5
Kozel, F.A.6
-
54
-
-
33745220053
-
VNS therapy in treatment-resistant depression: Clinical evidence and putative neurobiological mechanisms
-
Nemeroff CB, Mayberg HS, Krahl SE, McNamara J, Frazer A, Henry TR, et al. VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology 2006;31:1345-1355.
-
(2006)
Neuropsychopharmacology
, vol.31
, pp. 1345-1355
-
-
Nemeroff, C.B.1
Mayberg, H.S.2
Krahl, S.E.3
McNamara, J.4
Frazer, A.5
Henry, T.R.6
-
55
-
-
47949111241
-
Chronic vagus nerve stimulation for treatment-resistant depression decreases resting ventromedial prefrontal glucose metabolism
-
Pardo JV, Sheikh SA, Schwindt GC, Lee JT, Kuskowski MA, Surerus C, et al. Chronic vagus nerve stimulation for treatment-resistant depression decreases resting ventromedial prefrontal glucose metabolism. Neuroimage 2008;42:879-889.
-
(2008)
Neuroimage
, vol.42
, pp. 879-889
-
-
Pardo, J.V.1
Sheikh, S.A.2
Schwindt, G.C.3
Lee, J.T.4
Kuskowski, M.A.5
Surerus, C.6
-
56
-
-
23644458113
-
Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: An exploratory approach
-
Zobel A, Joe A, Freymann N, Clusmann H, Schramm J, Reinhardt M, et al. Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: an exploratory approach. Psychiatry Res 2005;139:165-179.
-
(2005)
Psychiatry Res
, vol.139
, pp. 165-179
-
-
Zobel, A.1
Joe, A.2
Freymann, N.3
Clusmann, H.4
Schramm, J.5
Reinhardt, M.6
-
57
-
-
0013986594
-
The pharmacology of imipramine and related antidepressants
-
Gyermek L. The pharmacology of imipramine and related antidepressants. Int Rev Neurobiol 1966;9:95-143.
-
(1966)
Int Rev Neurobiol
, vol.9
, pp. 95-143
-
-
Gyermek, L.1
-
58
-
-
0000076710
-
The pharmacology and biochemistry of depression
-
Prange AJ Jr. The pharmacology and biochemistry of depression. Dis Nerv Syst 1964;25:217-221.
-
(1964)
Dis Nerv Syst
, vol.25
, pp. 217-221
-
-
Prange Jr., A.J.1
-
59
-
-
0000264756
-
The catecholamine hypothesis of affective disorders: A review of supporting evidence
-
Schildkraut JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 1965;122:509-522.
-
(1965)
Am J Psychiatry
, vol.122
, pp. 509-522
-
-
Schildkraut, J.J.1
-
60
-
-
33745947013
-
Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission
-
Dorr AE, Debonnel G. Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. J Pharmacol Exp Ther 2006;318:890-898.
-
(2006)
J Pharmacol Exp Ther
, vol.318
, pp. 890-898
-
-
Dorr, A.E.1
Debonnel, G.2
-
61
-
-
70149083277
-
Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation
-
Manta S, Dong J, Debonnel G, Blier P. Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation. J Psychiatry Neurosci 2009;34:272-280.
-
(2009)
J Psychiatry Neurosci
, vol.34
, pp. 272-280
-
-
Manta, S.1
Dong, J.2
Debonnel, G.3
Blier, P.4
-
62
-
-
35448949501
-
Vagus nerve stimulation increases norepinephrine concentration and the gene expression of BDNF and bFGF in the rat brain
-
Follesa P, Biggio F, Gorini G, Caria S, Talani G, Dazzi L, et al. Vagus nerve stimulation increases norepinephrine concentration and the gene expression of BDNF and bFGF in the rat brain. Brain Res 2007;1179:28-34.
-
(2007)
Brain Res
, vol.1179
, pp. 28-34
-
-
Follesa, P.1
Biggio, F.2
Gorini, G.3
Caria, S.4
Talani, G.5
Dazzi, L.6
-
63
-
-
1242314311
-
The effects of peripheral vagal nerve stimulation at a memory-modulating intensity on norepinephrine output in the basolateral amygdala
-
Hassert DL, Miyashita T, Williams CL. The effects of peripheral vagal nerve stimulation at a memory-modulating intensity on norepinephrine output in the basolateral amygdala. Behav Neurosci 2004;118:79-88.
-
(2004)
Behav Neurosci
, vol.118
, pp. 79-88
-
-
Hassert, D.L.1
Miyashita, T.2
Williams, C.L.3
-
64
-
-
33750456540
-
Increased extracellular concentrations of norepinephrine in cortex and hippocampus following vagus nerve stimulation in the rat
-
Roosevelt RW, Smith DC, Clough RW, Jensen RA, Browning RA. Increased extracellular concentrations of norepinephrine in cortex and hippocampus following vagus nerve stimulation in the rat. Brain Res 2006;1119:124-132.
-
(2006)
Brain Res
, vol.1119
, pp. 124-132
-
-
Roosevelt, R.W.1
Smith, D.C.2
Clough, R.W.3
Jensen, R.A.4
Browning, R.A.5
-
65
-
-
84875926850
-
Electrophysiological and neurochemical effects of long-term vagus nerve stimulation on the rat monoaminergic systems
-
Manta S, El Mansari M, Debonnel G, Blier P. Electrophysiological and neurochemical effects of long-term vagus nerve stimulation on the rat monoaminergic systems. Int J Neuropsychopharmacol 2013;16:459-470.
-
(2013)
Int J Neuropsychopharmacol
, vol.16
, pp. 459-470
-
-
Manta, S.1
El Mansari, M.2
Debonnel, G.3
Blier, P.4
-
66
-
-
80054912841
-
Serotonergic and noradrenergic pathways are required for the anxiolytic-like and antidepressant-like behavioral effects of repeated vagal nerve stimulation in rats
-
Furmaga H, Shah A, Frazer A. Serotonergic and noradrenergic pathways are required for the anxiolytic-like and antidepressant-like behavioral effects of repeated vagal nerve stimulation in rats. Biol Psychiatry 2011;70:937-945.
-
(2011)
Biol Psychiatry
, vol.70
, pp. 937-945
-
-
Furmaga, H.1
Shah, A.2
Frazer, A.3
-
67
-
-
0023947879
-
The effects of chronic antidepressant treatment in an animal model of anxiety
-
Bodnoff SR, Suranyi-Cadotte B, Aitken DH, Quirion R, Meaney MJ. The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology (Berl) 1988;95(3):298-302.
-
(1988)
Psychopharmacology (Berl)
, vol.95
, Issue.3
, pp. 298-302
-
-
Bodnoff, S.R.1
Suranyi-Cadotte, B.2
Aitken, D.H.3
Quirion, R.4
Meaney, M.J.5
-
68
-
-
0017651126
-
Behavioral despair in mice: A primary screening test for antidepressants
-
Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977;229:327-336.
-
(1977)
Arch Int Pharmacodyn Ther
, vol.229
, pp. 327-336
-
-
Porsolt, R.D.1
Bertin, A.2
Jalfre, M.3
-
69
-
-
1542315615
-
Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action
-
Krahl SE, Senanayake SS, Pekary AE, Sattin A. Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action. J Psychiatr Res 2004;38:237-240.
-
(2004)
J Psychiatr Res
, vol.38
, pp. 237-240
-
-
Krahl, S.E.1
Senanayake, S.S.2
Pekary, A.E.3
Sattin, A.4
-
70
-
-
0033937168
-
Adult brain neurogenesis and psychiatry: A novel theory of depression
-
Jacobs BL, van Praag H, Gage FH. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatry 2000;5:262-269.
-
(2000)
Mol Psychiatry
, vol.5
, pp. 262-269
-
-
Jacobs, B.L.1
Van Praag, H.2
Gage, F.H.3
-
71
-
-
79959362201
-
Chronic vagus nerve stimulation induces neuronal plasticity in the rat hippocampus
-
Biggio F, Gorini G, Utzeri C, Olla P, Marrosu F, Mocchetti I, et al. Chronic vagus nerve stimulation induces neuronal plasticity in the rat hippocampus. Int J Neuropsychopharmacol 2009;12:1209-1221.
-
(2009)
Int J Neuropsychopharmacol
, vol.12
, pp. 1209-1221
-
-
Biggio, F.1
Gorini, G.2
Utzeri, C.3
Olla, P.4
Marrosu, F.5
Mocchetti, I.6
-
72
-
-
56349152549
-
Effects of vagus nerve stimulation on rat hippocampal progenitor proliferation
-
Revesz D, Tjernstrom M, Ben-Menachem E, Thorlin T. Effects of vagus nerve stimulation on rat hippocampal progenitor proliferation. Exp Neurol 2008;214:259-265.
-
(2008)
Exp Neurol
, vol.214
, pp. 259-265
-
-
Revesz, D.1
Tjernstrom, M.2
Ben-Menachem, E.3
Thorlin, T.4
-
73
-
-
84873407488
-
Vagus nerve stimulation ameliorated deficits in one-way active avoidance learning and stimulated hippocampal neurogenesis in bulbectomized rats
-
Gebhardt N, Bär KJ, Boettger MK, Grecksch G, Keilhoff G, Reichart R, et al. Vagus nerve stimulation ameliorated deficits in one-way active avoidance learning and stimulated hippocampal neurogenesis in bulbectomized rats. Brain Stimul 2013;6:78-83.
-
(2013)
Brain Stimul
, vol.6
, pp. 78-83
-
-
Gebhardt, N.1
Bär, K.J.2
Boettger, M.K.3
Grecksch, G.4
Keilhoff, G.5
Reichart, R.6
-
74
-
-
0034040357
-
Increased neurogenesis in a model of electroconvulsive therapy
-
Madsen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O, Tingström A. Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry 2000;47:1043-1049.
-
(2000)
Biol Psychiatry
, vol.47
, pp. 1043-1049
-
-
Madsen, T.M.1
Treschow, A.2
Bengzon, J.3
Bolwig, T.G.4
Lindvall, O.5
Tingström, A.6
-
75
-
-
80855123608
-
Depression, antidepressants, and neurogenesis: A critical reappraisal
-
Hanson ND, Owens MJ, Nemeroff CB. Depression, antidepressants, and neurogenesis: a critical reappraisal. Neuropsychopharmacology 2011;36:2589-2602.
-
(2011)
Neuropsychopharmacology
, vol.36
, pp. 2589-2602
-
-
Hanson, N.D.1
Owens, M.J.2
Nemeroff, C.B.3
-
76
-
-
0042528720
-
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
-
Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003;301:805-809.
-
(2003)
Science
, vol.301
, pp. 805-809
-
-
Santarelli, L.1
Saxe, M.2
Gross, C.3
Surget, A.4
Battaglia, F.5
Dulawa, S.6
-
77
-
-
84877287517
-
The neural plasticity theory of depression: Assessing the roles of adult neurogenesis and PSA-NCAM within the hippocampus
-
Wainwright SR, Galea LA. The neural plasticity theory of depression: assessing the roles of adult neurogenesis and PSA-NCAM within the hippocampus. Neural Plast 2013;2013:805497.
-
(2013)
Neural Plast
, vol.2013
, pp. 805497
-
-
Wainwright, S.R.1
Galea, L.A.2
-
78
-
-
34248388548
-
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
-
Warner-Schmidt JL, Duman RS. VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci U S A 2007;104:4647-4652.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 4647-4652
-
-
Warner-Schmidt, J.L.1
Duman, R.S.2
-
79
-
-
67349216843
-
The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling
-
739
-
Bessa JM, Ferreira D, Melo I, Marques F, Cerqueira JJ, Palha JA, et al. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry 2009;14:764-773, 739.
-
(2009)
Mol Psychiatry
, vol.14
, pp. 764-773
-
-
Bessa, J.M.1
Ferreira, D.2
Melo, I.3
Marques, F.4
Cerqueira, J.J.5
Palha, J.A.6
-
80
-
-
19944430637
-
Doublecortin expression levels in adult brain reflect neurogenesis
-
Couillard-Despres S, Winner B, Schaubeck S, Aigner R, Vroemen M, Weidner N, et al. Doublecortin expression levels in adult brain reflect neurogenesis. Eur J Neurosci 2005;21:1-14.
-
(2005)
Eur J Neurosci
, vol.21
, pp. 1-14
-
-
Couillard-Despres, S.1
Winner, B.2
Schaubeck, S.3
Aigner, R.4
Vroemen, M.5
Weidner, N.6
-
81
-
-
38949158786
-
Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells
-
Wang JW, David DJ, Monckton JE, Battaglia F, Hen R. Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. J Neurosci 2008;28:1374-1384.
-
(2008)
J Neurosci
, vol.28
, pp. 1374-1384
-
-
Wang, J.W.1
David, D.J.2
Monckton, J.E.3
Battaglia, F.4
Hen, R.5
-
82
-
-
84864208860
-
A neurotrophic hypothesis of depression: Role of synaptogenesis in the actions of NMDA receptor antagonists
-
Duman RS, Li N. A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists. Philos Trans R Soc Lond B Biol Sci 2012;367:2475-2484.
-
(2012)
Philos Trans R Soc Lond B Biol Sci
, vol.367
, pp. 2475-2484
-
-
Duman, R.S.1
Li, N.2
-
83
-
-
33745208951
-
A neurotrophic model for stress-related mood disorders
-
Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006;59:1116-1127.
-
(2006)
Biol Psychiatry
, vol.59
, pp. 1116-1127
-
-
Duman, R.S.1
Monteggia, L.M.2
-
84
-
-
0028815653
-
Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments
-
Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995;15:7539-7547.
-
(1995)
J Neurosci
, vol.15
, pp. 7539-7547
-
-
Nibuya, M.1
Morinobu, S.2
Duman, R.S.3
-
85
-
-
0029992189
-
Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus
-
Nibuya M, Nestler EJ, Duman RS. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 1996;16:2365-2372.
-
(1996)
J Neurosci
, vol.16
, pp. 2365-2372
-
-
Nibuya, M.1
Nestler, E.J.2
Duman, R.S.3
-
86
-
-
0038214658
-
Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain
-
Müller MB, Toschi N, Kresse AE, Post A, Keck ME. Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain. Neuropsychopharmacology 2000;23:205-215.
-
(2000)
Neuropsychopharmacology
, vol.23
, pp. 205-215
-
-
Müller, M.B.1
Toschi, N.2
Kresse, A.E.3
Post, A.4
Keck, M.E.5
-
87
-
-
84860441405
-
Vagal nerve stimulation rapidly activates brain-derived neurotrophic factor receptor TrkB in rat brain
-
Furmaga H, Carreno FR, Frazer A. Vagal nerve stimulation rapidly activates brain-derived neurotrophic factor receptor TrkB in rat brain. PLoS One 2012;7:e34844.
-
(2012)
PLoS One
, vol.7
-
-
Furmaga, H.1
Carreno, F.R.2
Frazer, A.3
-
88
-
-
34447121927
-
Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain
-
Rantamäki T, Hendolin P, Kankaanpää A, Mijatovic J, Piepponen P, Domenici E, et al. Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain. Neuropsychopharmacology 2007;32:2152-2162.
-
(2007)
Neuropsychopharmacology
, vol.32
, pp. 2152-2162
-
-
Rantamäki, T.1
Hendolin, P.2
Kankaanpää, A.3
Mijatovic, J.4
Piepponen, P.5
Domenici, E.6
-
89
-
-
0037218768
-
Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects
-
Saarelainen T, Hendolin P, Lucas G, Koponen E, Sairanen M, MacDonald E, et al. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci 2003;23:349-357.
-
(2003)
J Neurosci
, vol.23
, pp. 349-357
-
-
Saarelainen, T.1
Hendolin, P.2
Lucas, G.3
Koponen, E.4
Sairanen, M.5
MacDonald, E.6
-
90
-
-
84891770617
-
Activation of signaling pathways downstream of the brain-derived neurotrophic factor receptor, TrkB, in the rat brain by vagal nerve stimulation and antidepressant drugs
-
Carreno FR, Frazer A. Activation of signaling pathways downstream of the brain-derived neurotrophic factor receptor, TrkB, in the rat brain by vagal nerve stimulation and antidepressant drugs. Int J Neuropsychopharmacol 2014;17:247-258.
-
(2014)
Int J Neuropsychopharmacol
, vol.17
, pp. 247-258
-
-
Carreno, F.R.1
Frazer, A.2
-
91
-
-
49749101642
-
Serum brain-derived neurotrophic factor, depression, and antidepressant medications: Meta-analyses and implications
-
Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 2008;64:527-532.
-
(2008)
Biol Psychiatry
, vol.64
, pp. 527-532
-
-
Sen, S.1
Duman, R.2
Sanacora, G.3
-
92
-
-
0032404127
-
Transport of brain-derived neurotrophic factor across the blood-brain barrier
-
Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998;37:1553-1561.
-
(1998)
Neuropharmacology
, vol.37
, pp. 1553-1561
-
-
Pan, W.1
Banks, W.A.2
Fasold, M.B.3
Bluth, J.4
Kastin, A.J.5
-
93
-
-
77949658730
-
Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment
-
Cattaneo A, Bocchio-Chiavetto L, Zanardini R, Milanesi E, Placentino A, Gennarelli M. Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment. Int J Neuropsychopharmacol 2010;13:103-108.
-
(2010)
Int J Neuropsychopharmacol
, vol.13
, pp. 103-108
-
-
Cattaneo, A.1
Bocchio-Chiavetto, L.2
Zanardini, R.3
Milanesi, E.4
Placentino, A.5
Gennarelli, M.6
-
94
-
-
0037616364
-
Increased brain-derived neurotrophic factor expression in white blood cells of relapsing-remitting multiple sclerosis patients
-
Gielen A, Khademi M, Muhallab S, Olsson T, Piehl F. Increased brain-derived neurotrophic factor expression in white blood cells of relapsing-remitting multiple sclerosis patients. Scand J Immunol 2003;57:493-497.
-
(2003)
Scand J Immunol
, vol.57
, pp. 493-497
-
-
Gielen, A.1
Khademi, M.2
Muhallab, S.3
Olsson, T.4
Piehl, F.5
-
95
-
-
0034708618
-
Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor
-
Nakahashi T, Fujimura H, Altar CA, Li J, Kambayashi J, Tandon NN, et al. Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett 2000;470:113-117.
-
(2000)
FEBS Lett
, vol.470
, pp. 113-117
-
-
Nakahashi, T.1
Fujimura, H.2
Altar, C.A.3
Li, J.4
Kambayashi, J.5
Tandon, N.N.6
-
96
-
-
33745054958
-
Brain-derived neurotrophic factor serum concentrations in depressive patients during vagus nerve stimulation and repetitive transcranial magnetic stimulation
-
Lang UE, Bajbouj M, Gallinat J, Hellweg R. Brain-derived neurotrophic factor serum concentrations in depressive patients during vagus nerve stimulation and repetitive transcranial magnetic stimulation. Psychopharmacology (Berl) 2006;187:56-59.
-
(2006)
Psychopharmacology (Berl)
, vol.187
, pp. 56-59
-
-
Lang, U.E.1
Bajbouj, M.2
Gallinat, J.3
Hellweg, R.4
-
97
-
-
84878396787
-
Glutamate-based antidepressants: Preclinical psychopharmacology
-
Pilc A, Wierońska JM, Skolnick P. Glutamate-based antidepressants: preclinical psychopharmacology. Biol Psychiatry 2013;73:1125-1132.
-
(2013)
Biol Psychiatry
, vol.73
, pp. 1125-1132
-
-
Pilc, A.1
Wierońska, J.M.2
Skolnick, P.3
-
98
-
-
0030867369
-
The mesolimbic dopamine system as a target for rapid antidepressant action
-
Willner P. The mesolimbic dopamine system as a target for rapid antidepressant action. Int Clin Psychopharmacol 1997;12(Suppl 3):S7-S14.
-
(1997)
Int Clin Psychopharmacol
, vol.12
, Issue.SUPPL. 3
-
-
Willner, P.1
-
99
-
-
0025157918
-
Functional antagonists at the NMDA receptor complex exhibit antidepressant actions
-
Trullas R, Skolnick P. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol 1990;185:1-10.
-
(1990)
Eur J Pharmacol
, vol.185
, pp. 1-10
-
-
Trullas, R.1
Skolnick, P.2
-
100
-
-
0021990491
-
The tail suspension test: A new method for screening antidepressants in mice
-
Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 1985;85:367-370.
-
(1985)
Psychopharmacology (Berl)
, vol.85
, pp. 367-370
-
-
Steru, L.1
Chermat, R.2
Thierry, B.3
Simon, P.4
-
101
-
-
0033969685
-
Antidepressant effects of ketamine in depressed patients
-
Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000;47:351-354.
-
(2000)
Biol Psychiatry
, vol.47
, pp. 351-354
-
-
Berman, R.M.1
Cappiello, A.2
Anand, A.3
Oren, D.A.4
Heninger, G.R.5
Charney, D.S.6
-
102
-
-
77956499084
-
Glutamatergic modulators: The future of treating mood disorders?
-
Zarate C Jr, Machado-Vieira R, Henter I, Ibrahim L, Diazgranados N, Salvadore G. Glutamatergic modulators: the future of treating mood disorders? Harv Rev Psychiatry 2010;18:293-303.
-
(2010)
Harv Rev Psychiatry
, vol.18
, pp. 293-303
-
-
Zarate Jr., C.1
Machado-Vieira, R.2
Henter, I.3
Ibrahim, L.4
Diazgranados, N.5
Salvadore, G.6
-
103
-
-
79955993457
-
Rapid decrease in depressive symptoms with an N-methyl-D-aspartate antagonist in ECT-resistant major depression
-
Ibrahim L, Diazgranados N, Luckenbaugh DA, Machado-Vieira R, Baumann J, Mallinger AG, et al. Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:1155-1159.
-
(2011)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.35
, pp. 1155-1159
-
-
Ibrahim, L.1
Diazgranados, N.2
Luckenbaugh, D.A.3
Machado-Vieira, R.4
Baumann, J.5
Mallinger, A.G.6
-
104
-
-
77955891255
-
A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression
-
Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, Khalife S, et al. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 2010;67:793-802.
-
(2010)
Arch Gen Psychiatry
, vol.67
, pp. 793-802
-
-
Diazgranados, N.1
Ibrahim, L.2
Brutsche, N.E.3
Newberg, A.4
Kronstein, P.5
Khalife, S.6
-
105
-
-
33746896935
-
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
-
Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006;63:856-864.
-
(2006)
Arch Gen Psychiatry
, vol.63
, pp. 856-864
-
-
Zarate Jr., C.A.1
Singh, J.B.2
Carlson, P.J.3
Brutsche, N.E.4
Ameli, R.5
Luckenbaugh, D.A.6
-
106
-
-
84864286398
-
Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression
-
Zarate CA Jr, Brutsche N, Laje G, Luckenbaugh DA, Venkata SL, Ramamoorthy A, et al. Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression. Biol Psychiatry 2012;72:331-338.
-
(2012)
Biol Psychiatry
, vol.72
, pp. 331-338
-
-
Zarate Jr., C.A.1
Brutsche, N.2
Laje, G.3
Luckenbaugh, D.A.4
Venkata, S.L.5
Ramamoorthy, A.6
-
107
-
-
68049121850
-
Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression
-
Price RB, Nock MK, Charney DS, Mathew SJ. Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol Psychiatry 2009;66:522-526.
-
(2009)
Biol Psychiatry
, vol.66
, pp. 522-526
-
-
Price, R.B.1
Nock, M.K.2
Charney, D.S.3
Mathew, S.J.4
-
108
-
-
84880767967
-
Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression
-
Murrough JW, Perez AM, Pillemer S, Stern J, Parides MK, aan het Rot M, et al. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry 2013;74:250-256.
-
(2013)
Biol Psychiatry
, vol.74
, pp. 250-256
-
-
Murrough, J.W.1
Perez, A.M.2
Pillemer, S.3
Stern, J.4
Parides, M.K.5
Aan Het Rot, M.6
-
109
-
-
84855940822
-
Ketamine as a novel antidepressant: From synapse to behavior
-
Murrough JW. Ketamine as a novel antidepressant: from synapse to behavior. Clin Pharmacol Ther 2012;91:303-309.
-
(2012)
Clin Pharmacol Ther
, vol.91
, pp. 303-309
-
-
Murrough, J.W.1
-
110
-
-
80053025475
-
A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department
-
Larkin GL, Beautrais AL. A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department. Int J Neuropsychopharmacol 2011;14:1127-1131.
-
(2011)
Int J Neuropsychopharmacol
, vol.14
, pp. 1127-1131
-
-
Larkin, G.L.1
Beautrais, A.L.2
-
112
-
-
78650371169
-
Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder
-
DiazGranados N, Ibrahim LA, Brutsche NE, Ameli R, Henter ID, Luckenbaugh DA, et al. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry 2010;71:1605-1611.
-
(2010)
J Clin Psychiatry
, vol.71
, pp. 1605-1611
-
-
DiazGranados, N.1
Ibrahim, L.A.2
Brutsche, N.E.3
Ameli, R.4
Henter, I.D.5
Luckenbaugh, D.A.6
-
113
-
-
0031973147
-
Psychedelic effects of ketamine in healthy volunteers: Relationship to steady-state plasma concentrations
-
Bowdle TA, Radant AD, Cowley DS, Kharasch ED, Strassman RJ, Roy-Byrne PP. Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations. Anesthesiology 1998;88:82-88.
-
(1998)
Anesthesiology
, vol.88
, pp. 82-88
-
-
Bowdle, T.A.1
Radant, A.D.2
Cowley, D.S.3
Kharasch, E.D.4
Strassman, R.J.5
Roy-Byrne, P.P.6
-
115
-
-
0028323167
-
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses
-
Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994;51:199-214.
-
(1994)
Arch Gen Psychiatry
, vol.51
, pp. 199-214
-
-
Krystal, J.H.1
Karper, L.P.2
Seibyl, J.P.3
Freeman, G.K.4
Delaney, R.5
Bremner, J.D.6
-
116
-
-
79960057257
-
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
-
Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF, et al. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 2011;475:91-95.
-
(2011)
Nature
, vol.475
, pp. 91-95
-
-
Autry, A.E.1
Adachi, M.2
Nosyreva, E.3
Na, E.S.4
Los, M.F.5
Cheng, P.F.6
-
117
-
-
38349186799
-
Cellular mechanisms underlying the antidepressant effects of ketamine: Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors
-
Maeng S, Zarate CA Jr, Du J, Schloesser RJ, McCammon J, Chen G, et al. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino- 3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry 2008;63:349-352.
-
(2008)
Biol Psychiatry
, vol.63
, pp. 349-352
-
-
Maeng, S.1
Zarate Jr., C.A.2
Du, J.3
Schloesser, R.J.4
McCammon, J.5
Chen, G.6
-
118
-
-
79953166373
-
Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure
-
Li N, Liu RJ, Dwyer JM, Banasr M, Lee B, Son H, et al. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry 2011;69:754-761.
-
(2011)
Biol Psychiatry
, vol.69
, pp. 754-761
-
-
Li, N.1
Liu, R.J.2
Dwyer, J.M.3
Banasr, M.4
Lee, B.5
Son, H.6
-
119
-
-
35548991088
-
NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons
-
Homayoun H, Moghaddam B. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci 2007;27:11496-11500.
-
(2007)
J Neurosci
, vol.27
, pp. 11496-11500
-
-
Homayoun, H.1
Moghaddam, B.2
-
120
-
-
67650473167
-
Positive AMPA receptor modulation rapidly stimulates BDNF release and increases dendritic mRNA translation
-
Jourdi H, Hsu YT, Zhou M, Qin Q, Bi X, Baudry M. Positive AMPA receptor modulation rapidly stimulates BDNF release and increases dendritic mRNA translation. J Neurosci 2009;29:8688-8697.
-
(2009)
J Neurosci
, vol.29
, pp. 8688-8697
-
-
Jourdi, H.1
Hsu, Y.T.2
Zhou, M.3
Qin, Q.4
Bi, X.5
Baudry, M.6
-
121
-
-
80054101849
-
Signaling pathways underlying the rapid antidepressant actions of ketamine
-
Duman RS, Li N, Liu RJ, Duric V, Aghajanian G. Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology 2012;62:35-41.
-
(2012)
Neuropharmacology
, vol.62
, pp. 35-41
-
-
Duman, R.S.1
Li, N.2
Liu, R.J.3
Duric, V.4
Aghajanian, G.5
-
122
-
-
84891817325
-
Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression
-
Haile CN, Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Foulkes A, et al. Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression. Int J Neuropsychopharmacol 2014;17:331-336.
-
(2014)
Int J Neuropsychopharmacol
, vol.17
, pp. 331-336
-
-
Haile, C.N.1
Murrough, J.W.2
Iosifescu, D.V.3
Chang, L.C.4
Al Jurdi, R.K.5
Foulkes, A.6
-
123
-
-
84878384778
-
Activation of mammalian target of rapamycin and synaptogenesis: Role in the actions of rapid-acting antidepressants
-
Dwyer JM, Duman RS. Activation of mammalian target of rapamycin and synaptogenesis: role in the actions of rapid-acting antidepressants. Biol Psychiatry 2013;73:1189-1198.
-
(2013)
Biol Psychiatry
, vol.73
, pp. 1189-1198
-
-
Dwyer, J.M.1
Duman, R.S.2
-
124
-
-
79960544100
-
Monitoring ketamine treatment response in a depressed patient via peripheral mammalian target of rapamycin activation
-
Denk MC, Rewerts C, Holsboer F, Erhardt-Lehmann A, Turck CW. Monitoring ketamine treatment response in a depressed patient via peripheral mammalian target of rapamycin activation. Am J Psychiatry 2011;168:751-752.
-
(2011)
Am J Psychiatry
, vol.168
, pp. 751-752
-
-
Denk, M.C.1
Rewerts, C.2
Holsboer, F.3
Erhardt-Lehmann, A.4
Turck, C.W.5
-
125
-
-
84878395015
-
Acute increases in plasma mammalian target of rapamycin, glycogen synthase kinase-3 β, and eukaryotic elongation factor 2 phosphorylation after ketamine treatment in three depressed patients
-
Yang C, Zhou ZQ, Gao ZQ, Shi JY, Yang JJ. Acute increases in plasma mammalian target of rapamycin, glycogen synthase kinase-3 β, and eukaryotic elongation factor 2 phosphorylation after ketamine treatment in three depressed patients. Biol Psychiatry 2013;73:e35-e36.
-
(2013)
Biol Psychiatry
, vol.73
-
-
Yang, C.1
Zhou, Z.Q.2
Gao, Z.Q.3
Shi, J.Y.4
Yang, J.J.5
-
126
-
-
84868208976
-
Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients
-
Laje G, Lally N, Mathews D, Brutsche N, Chemerinski A, Akula N, et al. Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients. Biol Psychiatry 2012;72:e27-e28.
-
(2012)
Biol Psychiatry
, vol.72
-
-
Laje, G.1
Lally, N.2
Mathews, D.3
Brutsche, N.4
Chemerinski, A.5
Akula, N.6
|